- Home
- OPAD vs GDTC Comparison
OPAD vs GDTC Comparison
Compare OPAD & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- GDTC
- Stock Information
- Founded
- OPAD 2015
- GDTC 2018
- Country
- OPAD United States
- GDTC Singapore
- Employees
- OPAD N/A
- GDTC N/A
- Industry
- OPAD Real Estate
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- GDTC Health Care
- Exchange
- OPAD Nasdaq
- GDTC Nasdaq
- Market Cap
- OPAD 25.3M
- GDTC 28.0M
- IPO Year
- OPAD N/A
- GDTC 2023
- Fundamental
- Price
- OPAD $2.26
- GDTC $2.00
- Analyst Decision
- OPAD Hold
- GDTC Buy
- Analyst Count
- OPAD 5
- GDTC 1
- Target Price
- OPAD $2.38
- GDTC $5.00
- AVG Volume (30 Days)
- OPAD 182.8K
- GDTC 7.9K
- Earning Date
- OPAD 08-04-2025
- GDTC 01-01-0001
- Dividend Yield
- OPAD N/A
- GDTC N/A
- EPS Growth
- OPAD N/A
- GDTC N/A
- EPS
- OPAD N/A
- GDTC N/A
- Revenue
- OPAD $794,159,000.00
- GDTC $368,838.00
- Revenue This Year
- OPAD N/A
- GDTC $5.37
- Revenue Next Year
- OPAD $40.79
- GDTC N/A
- P/E Ratio
- OPAD N/A
- GDTC N/A
- Revenue Growth
- OPAD N/A
- GDTC N/A
- 52 Week Low
- OPAD $0.91
- GDTC $1.20
- 52 Week High
- OPAD $5.13
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- OPAD 90.78
- GDTC 40.10
- Support Level
- OPAD $1.31
- GDTC $2.01
- Resistance Level
- OPAD $1.52
- GDTC $2.22
- Average True Range (ATR)
- OPAD 0.31
- GDTC 0.09
- MACD
- OPAD 0.18
- GDTC -0.02
- Stochastic Oscillator
- OPAD 74.74
- GDTC 5.88
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.